Skip to main content
Quest Diagnostics

Hepatitis C Virus Clearance Cascade — United States, 2013–2022

Hepatitis C virus clearance cascade — United States, 2013–2022

Authors: Wester C, Osinubi A, Kaufman HW, Symum H, Meyer 3rd WA, Huang X, Thompson WW

MMWR Morb Mortal Wkly Rep. 2023;72(26):716-720. doi: 10.15585/mmwr.mm7226a3

Specialties: Infectious disease

Related content

Publication
Hepatitis C Virus Testing During Pregnancy Following Universal Screening Recommendations
Publication
Decreases in Hepatitis C Testing and Treatment During the COVID 19 Pandemic
Publication
Relationship Between Hepatitis C Virus (HCV) IgG Index Values and Quantitative HCV RNA Results in HCV IgG-Reactive Serum Samples
Test FAQ
Donor Testing
On-Demand Webinar
HBV Webinar: From Screening to Functional Cure

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.